ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB Committee Worried About Requirements for Comprehensive Centers, To Meet Again

May 27, 1988

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

NIH Describes Peer Review Process

July 12, 1996

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989

In Brief: Hong, Posner Awarded ACS Research Professorships; Hawaii Wins Center Grants

July 26, 1996